A Cluster-randomized Effectiveness Trial of a Physician-pharmacist Collaborative Model to Improve Blood Pressure Control

Overview

Journal Circ Cardiovasc Qual Outcomes

Specialty Cardiology & Vascular Diseases

Date 2010 Jul 22

PMID 20647575

Citations 29

Authors

Barry L Carter

William Clarke

Gail Ardery

Cynthia A Weber

Paul A James

Mark Vander Weg

Elizabeth A Chrischilles

Thomas Vaughn

Brent M Egan

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Numerous studies have demonstrated the value of team-based care to improve blood pressure (BP) control, but there is limited information on whether these models would be adopted in diverse populations. The purpose of this study was to evaluate whether a collaborative model between physicians and pharmacists can improve BP control in multiple primary care medical offices with diverse geographic and patient characteristics and whether long-term BP control can be sustained. This study is a randomized prospective trial in 27 primary care offices first stratified by the percentage of underrepresented minorities and the level of clinical pharmacy services within the office. Each office is then randomized to either a 9- or 24-month intervention or a control group. Patients will be enrolled in this study until 2012. The results of this study should provide information on whether this model can be implemented in large numbers of diverse offices, if it is effective in diverse populations, and whether BP control can be sustained long term.

Clinical Trial Registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00935077.

Citing Articles

Education programmes for people with chronic kidney disease and diabetes.

Cashmore B, Cooper T, Evangelidis N, Green S, Lopez-Vargas P, Tunnicliffe D Cochrane Database Syst Rev. 2024; 8:CD007374.

PMID: 39171639 PMC: 11339929. DOI: 10.1002/14651858.CD007374.pub3.

A cluster randomized trial to evaluate a centralized remote clinical pharmacy service in large, health system primary care clinics.

Kennelty K, Coffey C, Ardery G, Uribe L, Yankey J, Ecklund D J Am Coll Clin Pharm. 2023; 4(10):1287-1299.

PMID: 37265855 PMC: 10234512. DOI: 10.1002/jac5.1497.

The cost-effectiveness of pharmacist-physician collaborative care models vs usual care on time in target systolic blood pressure range in patients with hypertension: a payer perspective.

Jay J, Ijioma S, Holdford D, Dixon D, Sisson E, Patterson J J Manag Care Spec Pharm. 2021; 27(12):1680-1690.

PMID: 34818090 PMC: 10390951. DOI: 10.18553/jmcp.2021.27.12.1680.

Dissemination of a telehealth cardiovascular risk service: The CVRS live protocol.

Kennelty K, Engblom N, Carter B, Hollingworth L, Levy B, Finkelstein R Contemp Clin Trials. 2021; 102:106282.

PMID: 33444781 PMC: 8627195. DOI: 10.1016/j.cct.2021.106282.

A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP.

Polgreen L, Carter B, Polgreen P, Snyder P, Sewell D, Bayman E Contemp Clin Trials. 2020; 98:106169.

PMID: 33038500 PMC: 7686143. DOI: 10.1016/j.cct.2020.106169.

References

Milchak J, Carter B, Ardery G, Dawson J, Harmston M, Franciscus C . Physician adherence to blood pressure guidelines and its effect on seniors. Pharmacotherapy. 2008; 28(7):843-51. DOI: 10.1592/phco.28.7.843. View

Berlowitz D, Ash A, HICKEY E, Friedman R, Glickman M, Kader B . Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998; 339(27):1957-63. DOI: 10.1056/NEJM199812313392701. View

. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288(23):2981-97. DOI: 10.1001/jama.288.23.2981. View

Milchak J, Carter B, James P, Ardery G . Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature. Hypertension. 2004; 44(5):602-8. PMC: 1414061. DOI: 10.1161/01.HYP.0000144100.29945.5e. View

Dickerson L, Kraus C, Kuo G, Weber C, Bazaldua O, Tovar J . Formation of a primary care pharmacist practice-based research network. Am J Health Syst Pharm. 2007; 64(19):2044-9. DOI: 10.2146/ajhp060650. View

Thompson C . Pharmacists' CPT codes become permanent: next step is to set valuation for each code. Am J Health Syst Pharm. 2007; 64(23):2410-2. DOI: 10.2146/news07070099. View

Zwarenstein M, Treweek S, Gagnier J, Altman D, Tunis S, Haynes B . Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008; 337:a2390. PMC: 3266844. DOI: 10.1136/bmj.a2390. View

Donner A, Klar N . Statistical considerations in the design and analysis of community intervention trials. J Clin Epidemiol. 1996; 49(4):435-9. DOI: 10.1016/0895-4356(95)00511-0. View

Malone D, Carter B, Billups S, Valuck R, Barnette D, Sintek C . An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical.... Pharmacotherapy. 2000; 20(10):1149-58. DOI: 10.1592/phco.20.15.1149.34590. View

10.

Hyman D, Pavlik V . Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001; 345(7):479-86. DOI: 10.1056/NEJMoa010273. View

11.

Oliveria S, Lapuerta P, McCarthy B, LItalien G, Berlowitz D, Asch S . Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002; 162(4):413-20. DOI: 10.1001/archinte.162.4.413. View

12.

Von Muenster S, Carter B, Weber C, Ernst M, Milchak J, Steffensmeier J . Description of pharmacist interventions during physician-pharmacist co-management of hypertension. Pharm World Sci. 2007; 30(1):128-35. DOI: 10.1007/s11096-007-9155-6. View

13.

Milchak J, Carter B, Ardery G, Black H, Bakris G, Jones D . Development of explicit criteria to measure adherence to hypertension guidelines. J Hum Hypertens. 2006; 20(6):426-33. PMC: 1513124. DOI: 10.1038/sj.jhh.1002005. View

14.

Carter B, Ardery G, Dawson J, James P, Bergus G, Doucette W . Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009; 169(21):1996-2002. PMC: 2882170. DOI: 10.1001/archinternmed.2009.358. View

15.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360(9349):1903-13. DOI: 10.1016/s0140-6736(02)11911-8. View

16.

Carter B, Bergus G, Dawson J, Farris K, Doucette W, Chrischilles E . A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich). 2008; 10(4):260-71. PMC: 2453045. DOI: 10.1111/j.1751-7176.2008.07434.x. View

17.

Carter B, Rogers M, Daly J, Zheng S, James P . The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009; 169(19):1748-55. PMC: 2882164. DOI: 10.1001/archinternmed.2009.316. View

18.

Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289(19):2560-72. DOI: 10.1001/jama.289.19.2560. View

19.

Ardery G, Carter B, Milchak J, Bergus G, Dawson J, James P . Explicit and implicit evaluation of physician adherence to hypertension guidelines. J Clin Hypertens (Greenwich). 2007; 9(2):113-9. PMC: 8110017. DOI: 10.1111/j.1524-6175.2007.06112.x. View

20.

Billups S, Okano G, Malone D, Carter B, Valuck R, Barnette D . Assessing the structure and process for providing pharmaceutical care in Veterans Affairs medical centers. Am J Health Syst Pharm. 2000; 57(1):29-39. DOI: 10.1093/ajhp/57.1.29. View